Cambridge, USA-based Vesalius Therapeutics has entered into a multi-target strategic alliance with the UK’s GSK to discover ...
GlobalData on MSN21h
Are dry powder inhalers the key to sustainable respiratory care?Though prescribing climate-friendly dry powder inhalers is environmentally sound, some experts warn certain patients may be ...
DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...
There is no main sponsor, as Bonmati said, although Liga F does have deals with Puma, Panini, GSK, Mahou, Solan de Cabra and ...
From healthcare to banking, it is the software-of-choice for some of the biggest names in the UK market. Think AstraZeneca (AZN.L), GSK (GSK.L), Rolls-Royce (RR.L) and Lloyds (LLOY.L). Even the London ...
The global artificial intelligence (AI) in drug discovery market is projected to reach USD 6.89 billion by 2029 from USD 1.86 billion in ...
The FTSE 100 index slumped 99.42 points, 1.2%, at 8,025.77. The FTSE 250 closed down 295.73 points, 1.4%, at 20,427.80. The AIM All-Share fell 7.07 points, 1.0%, at 730.86.
Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
DelveInsight's Glucose Syrup Market Insights report provides the current and forecast market analysis, individual leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback